Our results provided a novel panel of AURKA, CDK1, TOP2A, CYP2C9, and CYP3A4 candidate genes for curcumin related chemotherapy of hepatocellular carcinoma. This evidence concerns the gene CYP2C9 and hepatocellular carcinoma.